Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Endo International

Endo International reported $5.57B in Assets for its fiscal quarter ending in March of 2023.

Assets Change
Amarin AMRN:US USD 860.19M 25.99M
ANI Pharmaceuticals ANIP:US USD 765.22M 5.14M
Coherus Biosciences CHRS:US USD 402.43M 78.42M
Eli Lilly LLY:US USD 53.16B 3.67B
Endo International ENDP:US USD 5.57B 191.83M
Heron Therapeutics HRTX:US USD 220.88M 30.07M
Hikma Pharmaceutical HIK:LN USD 4.47B 276M
Horizon Pharma HZNP:US USD 8.99B 121.17M
Ligand Pharmaceuticals LGND:US USD 811.08M 48.41M
Novartis NOVN:VX USD 112.24B 5.21B
Pacira PCRX:US USD 1.52B 157.78M
Patterson Companies PDCO:US USD 2.94B 61.52M
Perrigo PRGO:US USD 10.95B 62.4M
Phibro Animal Health PAHC:US USD 965.43M 3.6M
Revance Therapeutics RVNC:US USD 547.8M 34.1M
Supernus Pharmaceuticals SUPN:US USD 1.79B 89.3M
Takeda 4502:JP JPY 13.96T 453.04B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 43.46B 550M
Xeris Pharmaceuticals Inc XERS:US USD 321.36M 23.16M
Zoetis ZTS:US USD 13.75B 1.17B